SCHEMBL7031982

SCHEMBL7031982

COC(CC(=O)[O-])C[N+](C)(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
CYP1A2 P05177 1/20 0.67
HRH1 P35367 1/20 0.67
CYP2C19 P33261 2/20 0.62
RECQL P46063 1/20 0.62
SLC22A16 Q86VW1 1/20 0.57
CPT2 P23786 2/20 0.53
CPT1A P50416 2/20 0.53
SLC25A20 O43772 3/20 0.53
TP53 P04637 2/20 0.53
CYP2D6 P10635 2/20 0.53
TSHR P16473 2/20 0.53
SLC6A5 Q9Y345 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
NFKB1 P19838 1/20 0.53
THPO P40225 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28029014 0.98 MEN1 (0.65) MEN1KMT2ACYP1A2HRH1CYP2C19
Glutarate SCHEMBL10496229 0.89 MEN1 (0.56) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL4256715 0.87 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL17629809 0.87 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL1208087 0.87 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL28171779 0.83 MEN1 (0.67) MEN1KMT2ACYP1A2HRH1CYP2C19
Aspartic Acid SCHEMBL10496248 0.83 MEN1 (0.49) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL2994007 0.82 MEN1 (0.65) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL28768760 0.81 MEN1 (0.59) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL25099750 0.81 LMNA (0.63) MEN1KMT2ACYP1A2HRH1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US claimed
CN-106132407-A Fermented food extracts compositions 国立大学法人信州大学 2016-11-16 CN claimed
EP-3197445-B1 PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA SALAMA ZOSER B (DE) 2021-04-28 EP disclosed
US-10328051-B2 Proline or proline derivatives for the treatment of dementia SALAMA ZOSER B (DE) 2019-06-25 US disclosed
US-20170239215-A1 PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA SALAMA ZOSER B (DE) 2017-08-24 US disclosed
EP-3197445-A1 PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA Salama, Zoser B. (DE) 2017-08-02 EP disclosed
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US disclosed
WO-2016200364-A1 THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2016-12-15 WO disclosed
CN-106132407-A Fermented food extracts compositions 国立大学法人信州大学 2016-11-16 CN disclosed
WO-2016046162-A1 PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA SALAMA ZOSER B (DE) 2016-03-31 WO disclosed
EP-0770400-B1 Acyl-L-carnitine labelled on the secondary acyl carbon atom and diagnostic agents containing it JAPAN SCIENCE & TECH CORP (JP) 2003-02-26 EP disclosed
US-5837219-A Labelled acyl-L-carnitine and diagnostic agent JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 1998-11-17 US disclosed
EP-0770400-A2 Labelled acyl-L-carnitine and diagnostic agent Japan Science and Technology Corporation (JP) 1997-05-02 EP disclosed
US-4883786-A CARDIOTROPIC AGENTS MAGIS FARMACEUTICI SRL (IT) 1989-11-28 US disclosed
EP-0167115-B1 NEW DERIVATIVES OF L-CARNITINE MAGIS FARMACEUTICI S.P.A. (IT) 1988-04-20 EP disclosed
US-4710468-A FROM OPTICALLY ACTIVE SUBSTITUTED HYDROXYBUTYRIC ACID DERIVATIVES WITH OXIDOREDUCTASE SIGMA-TAU INDUSTRIE PHARMACEUTICHE RIUNITE S.P.A. (IT) 1987-12-01 US disclosed
EP-0167115-A2 New derivatives of L-carnitine MAGIS FARMACEUTICI S.P.A. (IT) 1986-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10328051-B2 Proline or proline derivatives for the treatment of dementia PSEN2, PSEN1, PRNP MEN1 4298/4885KMT2A 2678/4885CYP1A2 2826/4885
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION FIBP, PFKFB2, PFKFB1 MEN1 2308/4885KMT2A 2292/4885CYP1A2 4090/4885
US-20170239215-A1 PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA PSEN2, PSEN1, PRNP MEN1 4298/4885KMT2A 2678/4885CYP1A2 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.